Hypercoagulability states in upper-extremity deep venous thrombosis

被引:44
作者
Leebeek, FWG [1 ]
Stadhouders, NAM [1 ]
van Stein, D [1 ]
Gómez-García, EB [1 ]
Kappers-Klunne, MC [1 ]
机构
[1] Univ Hosp Rotterdam Dijkzigt, Dept Hematol, NL-3015 GD Rotterdam, Netherlands
关键词
deep vein thrombosis; upper extremity; prothrombin; factor V Leiden; central venous catheter;
D O I
10.1002/ajh.1070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Deep venous thrombosis of the upper extremity (DVTUE) is a rare thrombotic disorder that may occur spontaneously but is most often related to predisposing factors, such as an indwelling central venous catheter, malignancy, or exercise. The role of coagulation disorders, i.e., a hypercoagulable state in the pathogenesis of DVTUE is not well known. We have evaluated both genetic and acquired thrombophilia parameters in consecutive patients with DVTUE. A hypercoagulable state was found in 32% of the patients. The most frequent coagulation abnormality was the presence of lupus anticoagulant or anticardiolipin antibodies (27%). Factor V Leiden mutation was detected in two patients, antithrombin deficiency in one, and none of the patients had the prothrombin G20210A gene variant or protein C or S deficiency. The prevalence of coagulation abnormalities was not significantly different in a subgroup of patients with spontaneous DVTUE as compared to those with an obvious predisposing factor, such as an indwelling central venous catheter. We conclude that antiphospholipid antibodies are frequently found in patients with DVTUE. Factor V Leiden mutation, prothrombin 20210A gene variant, protein C deficiency, and protein S deficiency do not seem to play a major pathogenetic role in DVTUE. Am. J. Hematol. 67:15-19, 2001. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:15 / 19
页数:5
相关论文
共 18 条
[1]  
ABURAHMA AF, 1991, AM SURGEON, V57, P101
[2]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[3]   Frequent factor II G20210A mutation in idiopathic portal vein thrombosis [J].
Chamouard, P ;
Pencreach, E ;
Maloisel, F ;
Grunebaum, L ;
Ardizzone, JF ;
Meyer, A ;
Gaub, MP ;
Goetz, J ;
Baumann, R ;
Uring-Lambert, S ;
Levy, S ;
Dufour, P ;
Hauptmann, G ;
Oudet, P .
GASTROENTEROLOGY, 1999, 116 (01) :144-148
[4]   LUPUS ANTICOAGULANT ASSOCIATED WITH PRIMARY MALIGNANT LYMPHOPLASMACYTIC LYMPHOMA OF THE SPLEEN - A REPORT OF 4 PATIENTS [J].
CIAUDO, M ;
HORELLOU, MH ;
AUDOUIN, J ;
DECARBONNIERES, C ;
CONARD, J ;
SAMAMA, M .
AMERICAN JOURNAL OF HEMATOLOGY, 1991, 38 (04) :271-276
[5]   Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole blood [J].
Gómez, E ;
van der Poel, SCPAM ;
Jansen, JH ;
van der Reijden, BA ;
Löwenberg, B .
BLOOD, 1998, 91 (06) :2208-2209
[6]   Hypercoagulable states in primary upper-extremity deep vein thrombosis [J].
Héron, E ;
Lozinguez, O ;
Alhenc-Gelas, M ;
Emmerich, J ;
Fiessinger, JN .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (03) :382-386
[7]  
Hicken GJ, 1998, CAN J SURG, V41, P13
[8]   Current concepts - Disseminated intravascular coagulation [J].
Levi, M ;
ten Cate, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :586-592
[9]   Upper-extremity deep venous thrombosis. A report of 49 cases. [J].
Marie, I ;
Levesque, H ;
Cailleux, N ;
Primard, E ;
Peillon, C ;
Watelet, J ;
Courtois, H .
REVUE DE MEDECINE INTERNE, 1998, 19 (06) :399-408
[10]   High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives [J].
Martinelli, I ;
Sacchi, E ;
Landi, G ;
Taioli, E ;
Duca, F ;
Mannucci, PM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) :1793-1797